297 related articles for article (PubMed ID: 19652095)
1. Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor.
An X; Jin Y; Guo H; Foo SY; Cully BL; Wu J; Zeng H; Rosenzweig A; Li J
Circulation; 2009 Aug; 120(7):617-27. PubMed ID: 19652095
[TBL] [Abstract][Full Text] [Related]
2. Kallistatin is a new inhibitor of angiogenesis and tumor growth.
Miao RQ; Agata J; Chao L; Chao J
Blood; 2002 Nov; 100(9):3245-52. PubMed ID: 12384424
[TBL] [Abstract][Full Text] [Related]
3. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
Sato Y; Sonoda H
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
5. Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.
Wang JN; Shi N; Xie WB; Guo X; Chen SY
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):e19-26. PubMed ID: 21636805
[TBL] [Abstract][Full Text] [Related]
6. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.
Giannarelli C; Alique M; Rodriguez DT; Yang DK; Jeong D; Calcagno C; Hutter R; Millon A; Kovacic JC; Weber T; Faries PL; Soff GA; Fayad ZA; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2014 Oct; 130(15):1274-86. PubMed ID: 25116956
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
9. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin-3F is an inhibitor of tumor angiogenesis.
Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G
Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832
[TBL] [Abstract][Full Text] [Related]
11. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis.
Goukassian D; Díez-Juan A; Asahara T; Schratzberger P; Silver M; Murayama T; Isner JM; Andrés V
FASEB J; 2001 Sep; 15(11):1877-85. PubMed ID: 11532967
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism.
Theurl M; Schgoer W; Albrecht K; Jeschke J; Egger M; Beer AG; Vasiljevic D; Rong S; Wolf AM; Bahlmann FH; Patsch JR; Wolf D; Schratzberger P; Mahata SK; Kirchmair R
Circ Res; 2010 Nov; 107(11):1326-35. PubMed ID: 20930149
[TBL] [Abstract][Full Text] [Related]
16. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
17. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
18. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.
Ozawa K; Kondo T; Hori O; Kitao Y; Stern DM; Eisenmenger W; Ogawa S; Ohshima T
J Clin Invest; 2001 Jul; 108(1):41-50. PubMed ID: 11435456
[TBL] [Abstract][Full Text] [Related]
19. Arrb2 promotes endothelial progenitor cell-mediated postischemic neovascularization.
Wang X; Huang G; Mu J; Cong Z; Chen S; Fu D; Qi J; Li Z
Theranostics; 2020; 10(21):9899-9912. PubMed ID: 32863967
[No Abstract] [Full Text] [Related]
20. sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.
Kim BR; Seo SH; Park MS; Lee SH; Kwon Y; Rho SB
Oncotarget; 2015 Oct; 6(31):31830-43. PubMed ID: 26378810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
